Myrbetriq

Myrbetriq is a medication used to treat overactive bladder in adults. It is a once-daily tablet that is taken orally. Myrbetriq is a beta-3 adrenergic receptor agonist, which means that it works by stimulating the beta-3 receptors in the bladder muscle to relax the muscle and reduce the risk of urine leakage.

Myrbetriq is prescribed to treat urge incontinence, which is the loss of bladder control that causes a sudden, strong need to urinate. It is also prescribed to treat urgency urinary incontinence, which is the loss of bladder control that causes a feeling of urgency to urinate.

The safety and effectiveness of Myrbetriq have been established in clinical trials involving patients with overactive bladder. The medication has been shown to significantly reduce the frequency of urination, reduce the risk of urine leakage, and improve the quality of life for patients.

Common side effects of Myrbetriq include cough, constipation, and headache. In rare cases, Myrbetriq can cause more serious side effects, such as changes in blood pressure, vision problems, and increased intraocular pressure.

Myrbetriq is available in a range of doses, including 50mg and 100mg tablets. It should be taken once daily with food or without food. Myrbetriq may interact with certain medications, including beta blockers, and may cause changes in blood pressure. Patients taking Myrbetriq should follow their doctor's instructions and report any side effects to their healthcare provider.